Abstract :
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.cyto.2011.09.002 Byline: Hakan Parlakpinar (a), Mehmet Kaya Ozer (b), Ahmet Acet (a) Keywords: Captopril; Losartan; PD123319; AT.sub.2 receptor; Myocardial ischemia-reperfusion Abstract: a* Captopril and losartan showed beneficial effects against MI/R-induced cardiac injury. a* Our cardioprotective findings were confirmed by TTC staining method and hemodynamic parameters. a* The cardioprotective mechanism was discussed in the view of angiotensin receptors (AT.sub.1 and AT.sub.2). a* AT.sub.2 receptor agonists could be a function for prevention from MI/R injury. Author Affiliation: (a) Division of Pharmacology, Department of Medicine, University of Inonu, 44280 Malatya, Turkey (b) Division of Pharmacology, Department of Medicine, University of Suleyman Demirel, Isparta, Turkey Article History: Received 6 July 2011; Revised 5 August 2011; Accepted 2 September 2011